# Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy

> **NCT00871208** · PHASE4 · WITHDRAWN · sponsor: **St. Luke's-Roosevelt Hospital Center**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Altabax (R)
- **DRUG:** Vehicle and Locoid lipocream (R)

## Key facts

- **NCT ID:** NCT00871208
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding withdrawn
- **Last updated:** 2015-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871208, "Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00871208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*